Alaven Pharmaceutical Acquires DrNatura Line of Consumer Health Remedies

December 15, 2008, Teaneck, NJ. DFW Capital Partners announced today that its portfolio company, Alaven Pharmaceutical, has acquired the assets of DrNatura, a leading web-based direct-to-consumer marketer of colon and digestive health products. As part of the transaction, Alaven created a separate subsidiary, Alaven Consumer Health, to house DrNatura and Alaven’s other OTC Alaven products.… Read more »

DFW Capital Partners closes the acquisition of The Copernicus Group IRB

DFW Capital Partners announced today that it has led the acquisition of a majority interest in The Copernicus Group IRB, from its founding owners. DFW recruited pharmaceutical industry veteran, Bruce Tomason, to become CEO of Copernicus and lead the business post-acquisition. DFW completed this investment, in part, with funds from its most recent private equity… Read more »

DFW Capital Partners successfully exits its investment in ConsoliDent

DFW Capital Partners announced today that it has completed the sale of its portfolio company, ConsoliDent to Great Expressions Dental, a portfolio company of Audax Group. DFW realized a 2.2x aggregate ROI on its investment in ConsoliDent. DFW originally invested in ConsoliDent, a leading regional dental practice management company, in 1998, as the company established… Read more »